How do I find out if I qualify for a stage iii hepatocellular carcinoma ajcc v8 study in California?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in California to take part?

Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a stage iii hepatocellular carcinoma ajcc v8 trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · California

Stage III Hepatocellular Carcinoma AJCC v8 clinical trials in California

We’re tracking 3 recruiting stage iii hepatocellular carcinoma ajcc v8 studies with a site in California — including Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in California

NCT04430452RecruitingPhase 2
Durvalumab with or without tremelimumab after liver radiation
This study tests whether the immunotherapy drugs durvalumab (with or without tremelimumab) can help control hepatocellular carcinoma (liver cancer) after you receive palliative, targeted radiation. It especially focuses on people whose cancer continued to grow after, or without, certain prior immune therapies.
San Francisco, CaliforniaAges 18 years+
NCT06811116RecruitingPhase 1/Phase 2
Adding sapanisertib to cabozantinib for beta-catenin mutant liver cancer
This trial tests whether adding a new drug (sapanisertib) to the usual chemotherapy (cabozantinib) can help people with advanced liver cancer that has a specific genetic change (beta-catenin mutation). It is for patients who have already had at least one prior treatment and are looking for a new option.
Irvine, CaliforniaAges 18 years+
NCT07166406RecruitingPhase 3
Immunotherapy with or without targeted radiation for advanced liver cancer
This trial tests whether adding a precise, targeted form of radiation (called SBRT) to standard immunotherapy (atezolizumab and bevacizumab) can help people with advanced liver cancer that has spread to the blood vessels or outside the liver. You may be asked to participate in one of two treatment groups to see which approach works better.
Berkeley, CaliforniaAges 18 years+

Stage III Hepatocellular Carcinoma AJCC v8 trials by city in California

Where these studies are running in California

Institutions with a site for the recruiting stage iii hepatocellular carcinoma ajcc v8 studies listed above.

UC Irvine Health · 2 studies
University of California, Irvine Medical Center / UC Irvine Health · 2 studies
Alta Bates Summit Medical Center
California Pacific Medical Center
Palo Alto Medical Foundation
Palo Alto Medical Foundation - Sunnyvale
Sutter Cancer Centers Radiation Oncology Services - Roseville
Sutter Cancer Centers Radiation Oncology Services-Cameron Park

What taking part in a stage iii hepatocellular carcinoma ajcc v8 study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Stage III Hepatocellular Carcinoma AJCC v8 trials in other states

Common questions

Are there stage iii hepatocellular carcinoma ajcc v8 clinical trials in California?: Yes. We're currently tracking 3 recruiting stage iii hepatocellular carcinoma ajcc v8 studies with a site in California, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a stage iii hepatocellular carcinoma ajcc v8 study in California?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in California to take part?: Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a stage iii hepatocellular carcinoma ajcc v8 trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New stage iii hepatocellular carcinoma ajcc v8 studies open in California regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.